Foresite Capital

Offices: Larkspur (United States), West Hollywood (United States), New York (United States)

Investment Stages: Series A, Series B, Series C

Markets: Healthcare, Life Sciences, Biotechnology, Therapeutics

Founded Year: 2011

Investor Type: Venture Capital, Private Equity

Portfolio Companies: 10x Genomics, Aclaris Therapeutics, Inc., Adaptimmune Therapeutics PLC, Adaptive Biotechnologies Corporation, Aduro Biotech, Aetion, Affinivax, Aimmune Therapeutics, Inc., Alector, Altos Labs, Alumis, Inc., ALX Oncology, Ambit Biosciences Corporation, Anacor Pharmaceuticals, Inc., Arcus Biosciences, Inc., Audentes Therapeutics, Auspex Pharmaceuticals, Inc., Avanir Pharmaceuticals, Inc., Avenzo Therapeutics, Avexis, Biotie Therapies, Bit Bio Limited, Candid Therapeutics, Casi Pharmaceuticals, Cerevance, CG Oncology, Chimagen Biosciences, Color Health, ConnectiveRx, Crossover Health, Inc., Cue Health, Cullinan Therapeutics, Delfi Diagnostics, Denali Therapeutics, Inc., Detect, Inc., Disc Medicine, DNAnexus, Inc., Dyax Corp, Eikon Therapeutics, Element Biosciences, Engrail Therapeutics, Everly Health, Evonetix, Fabric Genomics, Inc., Foresight Diagnostics, Fulcrum Therapeutics, Galileo, Generation Bio, Genomics PLC, GRAIL, Inc., HealthVerity, Hims & Hers, identifeye HEALTH, ImmPACT Bio USA, Inscripta, insitro, Intellia Therapeutics, Inc., Interline Therapeutics, Invivyd, Ivantis, Inc., Jounce Therapeutics, Inc., Juno Therapeutics, Karyopharm Therapeutics, Keros Therapeutics, Kiniksa Pharmaceuticals, Kinnate Biopharma, Kira Pharmaceuticals, Kriya Therapeutics, Kura Oncology, Latigo Biotherapeutics, LifeMine Therapeutics, Lyell Immunopharma, Mammoth Biosciences, Maze Therapeutics, MyOme, Inc., Mythic Therapeutics, NeuroDerm, Nexvet Biopharma PLC, Nurix Therapeutics, Odyssey Therapeutics, Orchard Therapeutics, Oric Pharmaceuticals, Inc., Peloton Therapeutics, Inc., Pharvaris, Pleno, ProQR Therapeutics NV, Protagonist Therapeutics, Inc., Quantum-Si, Redesign Health, REGENXBIO, Inc., Relay Therapeutics, Remix Therapeutics, Replimune Group, Inc., RxSight, SAGE Therapeutics, Inc., Seaport Therapeutics, Seranova Bio, Sestina Bio, Signant Health, Solid Biosciences, Sollis Health, Solta Medical, Inc., SomaLogic, Tasso, Inc., TenSixteen Bio, The Medicines Company, Theseus Pharmaceuticals, Thyme Care, Turning Point Therapeutics, Twist Bioscience, Vaxcyte, Velia, VelosBio Inc., Venatorx Pharmaceuticals, Inc., Verona Pharma PLC, Vitae Pharmaceuticals, Inc., Wave Life Sciences LTD., Wavetec Vision Systems, Inc., Xaira Therapeutics, XinThera

Website: https://www.foresitecapital.com

Team Page: https://www.foresitecapital.com/people/

Portfolio Link: https://www.foresitecapital.com/portfolio/

LinkedIn: https://www.linkedin.com/company/foresite-capital-management/

Twitter: https://twitter.com/foresitecapital

Instagram:

Crunchbase: https://www.crunchbase.com/organization/foresite-capital

Pitchbook: https://pitchbook.com/profiles/investor/54064-81